Glymphatic Impairment in Multiple Sclerosis: A New Pathological Mechanism Associated with Disease Burden (S5.010) — Antonio Carotenuto (2022) | RDL Network
Glymphatic Impairment in Multiple Sclerosis: A New Pathological Mechanism Associated with Disease Burden (S5.010)
Article 2022 en
Authors
AC
Antonio Carotenuto
LC
Laura Cacciaguerra
EP
Elisabetta Pagani
Abstract
1 min read
To assess glymphatic function in multiple sclerosis (MS) and to evaluate the association between glymphatic function, clinical disability, disease course, white (WM) and gray matter (GM) lesions and atrophy and WM microstructural damage.
Maria A. Rocca, Laura Parisi, Elisabetta Pagani, Massimiliano Copetti, Mariaemma Rodegher, Bruno Colombo, Gıancarlo Comı, Andrea Falini, Massimo Filippi
Paolo Preziosa, Maria A. Rocca, Matteo Atzori, Frederik Barkhof, Nicola De Stefano, Christian Enzinger, Franz Fazekas, Antonio Gallo, Hanneke E. Hulst, Laura Mancini, Xavier Montalbán, Elisabetta Pagani, Àlex Rovira, Maria Laura Stromillo, Gioacchino Tedeschi, Gıancarlo Comı, Massimo Filippi
Paolo Preziosa, Maria A. Rocca, Manfredo Atzori, Frederik Barkhof, Nicola De Stefano, Christian Enzinger, Franz Fazekas, Antonio Gallo, Hanneke E. Hulst, Laura Mancini, Xavier Montalbán, Elisabetta Pagani, Àlex Rovira, ML Stromillo, Gioacchino Tedeschi, Giacomo P. Comi, Massimo Filippi
Paolo Preziosa, Maria A. Rocca, Elisabetta Pagani, Maria Laura Stromillo, Christian Enzinger, Antonio Gallo, Hanneke E. Hulst, Matteo Atzori, Deborah Pareto, Gianna Carla Riccitelli, Massimiliano Copetti, Nicola De Stefano, Franz Fazekas, Alvino Bisecco, Frederik Barkhof, Tarek Yousry, María Jesús Arévalo, Massimo Filippi
Discussion(0)
No comments yet. Be the first to comment.